Endocare, an Irvine, CA-based company focused on tissue and tumor ablation, has raised $7 million in a private placement of common stock to Seattle-based Frazier Healthcare Ventures. In a statement, Endocare CEO Craig […]
Global Cancer Consortium
Inovio’s Delivery Technology Boosts Cancer Vax Potency
Data released yesterday from a study of an experimental prostate cancer vaccine showed that Inovio Biomedical‘s delivery system significantly enhanced the vaccine’s potency. In the Phase I/II study, some patients received the […]
Champions Biotechnology to Buy Biomerk
Champions Biotechnology, of Arlington, VA, announced today plans to buy Biomerk, a private company formed just last year to develop its trademark Tumorgrafts, a preclinical platform of human cancer tumor immune-deficient mice […]
Robotic Devices Move Into the Mainstream…and Beyond
Cardiogenesis, an Irvine, CA-based medical device company that specializes in devices that stimulate cardiac angiogenesis, submitted a PMA last week for its minimally invasive Robotic 5.0 PEARL Delivery System. The PEARL, which stands […]
Nanotech Investments Come with Risk
An article published today by Nanowerk says that today’s hefty investments in nanotechnology come with risk. Nanotech applied to diagnostics has raised hopes that diagnosis will eventually be possible at the cellular […]
Entrepreneurial Activity Spikes in North Carolina
Life sciences startups are popping up — and looking for money — in the Research Triangle Park section of North Carolina, says an article from today’s The News & Observer. “At least […]
Cliff Notes to the Times’ Diagnostics Special Section
Yesterday’s New York Times had a special section — a “user’s guide” — on diagnostic testing. It covers asthma, bone disease, cancer, heart disease, obesity, diabetes, AIDS and glaucoma. Don’t have time […]
High Hopes for New Prostate-Cancer Test
Results released today from a study of a new test for prostate cancer have raised spirits in the medical community and at the private Seattle firm that discovered it. Onconome‘s blood test measures […]
